Myeloma Masters: The Ultimate Myeloma Patient Care Quiz Show

This CNE activity is a collaboration of Rush University Medical Center, RedMedEd, and the Multiple Myeloma Research Foundation.

Support for this activity has been provided through educational grants from Amgen Inc., Celgene Corporation, and Takeda Oncology.

Scroll to the Bottom of this Information to Begin this Course

Release date: April 4, 2019

Valid through: April 4, 2020

Specialty: Oncology

Topic: Hematology/Oncology, Hematology, Oncology

Estimated Time to Complete Activity: 30 minutes

Target Audience

This activity has been designed to meet the educational needs of oncology nurses, advanced oncology certified nurse practitioners, and other health care professionals involved in the care of patients with multiple myeloma.

Program Overview

Keeping pace with the rapid advances in multiple myeloma patient care presents a considerable challenge to health care providers—and potentially leaves patients at a loss to understand their disease and the options available for managing it. In the format of an entertaining interactive game (think Who Wants to Be a Millionaire), this activity tests players’ knowledge of current and emerging myeloma patient care best practices. Along the way—using a range of multimedia prompts and hints—the game presents and reviews critical, evidence-based, clinical content. As players correctly answer questions, they accumulate points that will—hopefully!—earn them the title of Myeloma Master.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Interpret cytogenetic, molecular, and other standard staging tests to define multiple myeloma patient subsets
  • Distinguish between the indicated uses, mechanisms of action, and safety of myeloma treatment regimens
  • Describe the toxicity profile for newer agents used for the treatment of patients with multiple myeloma
  • Create patient-centered management plans with patients and other members of the care team to provide education and to minimize the impact of treatment-related side effects

Credit Available

  • Nurses: 0.5 Nurse Contact Hour

All other health care professionals completing this course will be issued a statement of participation.



Amy E. Pierre, RN, MSN, ANP-BC

Oncology Nurse Practitioner
Memorial Sloan Kettering Cancer Center
Montvale, New Jersey


Angela M. Vickroy, ANP-BC, OCN

Adult Nurse Practitioner
Barnes-Jewish Hospital
Washington University School of Medicine
St. Louis, Missouri

Accreditation Statement

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the health care team.

This activity is being presented without bias and with commercial support.

Credit Designation

ANCC Credit Designation – Nurses.

The maximum number of hours awarded for this CE activity is 0.5 contact hour.

Disclosures of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support, all continuing education providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the continuing education activity content over which the individual has control. Relationship information appears below:

Amy Pierre, RN, MSN, ANP-BC, has disclosed the following relevant financial relationships:
Speakers Bureau: Amgen

Angela M. Vickroy, ANP-BC, OCN, has disclosed the following relevant financial relationships:
Speakers Bureau: Amgen, Bristol-Myers Squibb, Celgene, Janssen, Takeda

Rush University Medical Center

Beth-Anne M. Christopher, MS, RN, CNL, Assistant Professor, Adult Health & Gerontological Nursing, has disclosed no relevant financial relationships.

Multiple Myeloma Research Foundation

Mary DeRome, Director of Medical Communications and Education, has disclosed no relevant financial relationships.


Denise C. LaTemple, PhD, Director of Scientific Services, has disclosed no relevant financial relationships.

Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.

Instructions for Participation and Credit

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive continuing education credit, participants must complete a full round of the game (achieving the required score) and the program activity evaluation. Certificates can be printed immediately.

Hardware and Software Requirements

  • Apple iPad or iPhones (iOS 11 or higher) with an Internet connection
  • A computer with an Internet connection
    • Internet browser (PC): Google Chrome, Internet Explorer 11 or higher, or Firefox 66.0.2 or higher
    • Internet browser (Mac): Google Chrome, Firefox 66.0.2, or Safari 10.14 or higher
    • Additional software: Adobe Flash Player and/or an HTML 5-capable browser is required for video or audio playback; Adobe Acrobat Reader may occasionally be required

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Rush University Medical Center, the Multiple Myeloma Research Foundation, RedMedEd, Amgen Inc., Celgene Corporation, and Takeda Oncology do not recommend the use of any agent outside the labeled indications.


The information presented at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a nurse regarding diagnosis and treatment of a specific patient’s medical condition.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Rush University Medical Center, the Multiple Myeloma Research Foundation, RedMedEd, Amgen Inc., Celgene Corporation, or Takeda Oncology. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Contact Information

Accreditation support: contact Rush University Medical Center, Continuing Education Department at

Technical support: for technical questions related to this activity or issues with your certificate, please contact RedMedEd at (610) 251-6841 or